Singular Genomics Systems Inc.
13F holders, Q3 2025 (September 30)1holders −41
1new positions
0sold out
$140.44avg. 13F price*
At the end of Q3 2025, 1 institutions reported holding Singular Genomics Systems Inc. in their 13F filings, down 41 from Q1 2024. 1 opened new positions and 0 sold out. The largest holder was Virtue Capital Management, LLC ($513K).
- Company
- Singular Genomics Systems Inc.
- Filed as
- OPTIMA MED INNOVATIONS F (Q3 2025)
- CUSIP
- 82933R100
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $513K |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q3 2025: 3,651 shares bought, net +3,651 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Virtue Capital Management, LLC | 0.08% | New | 3,651 | $513K |
"% of holder's portfolio" is SINGULAR GENOMICS SYSTEMS IN's weight in each manager's 13F, not the share of Singular Genomics Systems Inc. the manager owns.